49 completed. 49 Phase 2, 6 Phase 3, 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 49 | Completed 49 |
| Phase 3 | 6 | Completed 6 |
| Phase 1 | 5 | Completed 5 |
Follow Menstruation Disturbances: new trials by email Literature Review of Menstruation Disturbances trials Research Report on Menstruation Disturbances
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder Yaz, Placebo - Premenstrual Dysphoric Disorder, Bipolar Disorder | Phase 2 | Completed | St. Joseph's Healthcare Hamilton | 17 | 2023-02-03 | 2024-09-23 |
| Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25 Cramp Bites by Aunt Flo's Kitchen - Dysmenorrhea Primary, Dysmenorrhea | Phase 2 / Phase 3 | Completed | Cornell University | 12 | 2022-07-21 | 2024-04-12 |
| Dark Chocolate, Coconut Water, and Ibuprofen in Managing Primary Dysmenorrhea Ibuprofen 400 mg, Young Coconut Water, Dark Chocolate Bar - Dysmenorrhea Primary, Menstrual Pain | Phase 2 | Completed | Universitas Padjadjaran | 45 | 2022-06-30 | 2023-08-02 |
| Effect of Acupuncture and Low Caloric Diet on Primary Hypothyroidism and Irregular Menstruation in Infertile Women acupuncture, Thyroxine, low caloric diet - Primary Hypothyroidism, Acupuncture | Phase 2 | Completed | Cairo University | 60 | 2020-08-30 | 2023-04-07 |
| Effect of Melatonin on Reduction of Pelvic Pain Melatonin 10 mg, Placebo, Melatonin 20 mg - Dysmenorrhea, Endometriosis | Phase 2 | Completed | Karolinska Institutet | 80 | 2019-03-15 | 2022-04-05 |
| A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD) Sepranolone (UC1010) low dose, Sepranolone (UC1010) high dose, Placebo - Premenstrual Dysphoric Disorder | Phase 2 | Completed | Asarina Pharma | 475 | 2018-04-20 | 2020-10-28 |
| The Effectiveness and Safety of LIVIA® Transcutaneous Electrical Nerve Stimulation (TENS) in Women Suffering From Primary Dysmenorrhea. Livia - Dysmenorrhea | Phase 2 | Completed | iPulse Medical Ltd. (Livia) | 63 | 2017-06-01 | 2018-05-01 |
| Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women 17beta Estradiol, Transdermal placebo patch, Progesterone - Estrogen Deficiency, Cardiovascular Disease (CVD) | Phase 2 | Completed | Cedars-Sinai Medical Center | 29 | 2017-01-01 | 2025-03-13 |
| A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis Placebo, OBE2109 - Endometriosis | Phase 2 | Completed | ObsEva SA | 328 | 2016-07-01 | 2022-07-21 |
| Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study Oxytocin, Placebo - Premenstrual Dysphoric Disorder | Phase 2 / Phase 3 | Completed | University of North Carolina, Chapel Hill | 10 | 2015-07-01 | 2017-06-27 |
| Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids Vilaprisan (BAY1002670), Vilaprisan (BAY1002670, Ulipristal - Leiomyoma | Phase 2 | Completed | Bayer | 120 | 2015-06-01 | 2016-11-22 |
| The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea 20% Ethanol, Viburnum opulus 3X - Dysmenorrhea | Phase 2 | Completed | University of Johannesburg | 30 | 2015-02-01 | 2016-05-19 |
| The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome Individualised Homoeopathic Remedy - Premenstrual Syndrome | Phase 2 | Completed | University of Johannesburg | 10 | 2014-09-01 | 2016-05-19 |
| An Observational Study on the Efficacy of Individualised Homoeopathic Treatment on Premenstrual Syndrome Individualised Homeopathic Remedy - Premenstrual Syndrome | Phase 2 | Completed | University of Johannesburg | 10 | 2014-08-01 | 2016-05-19 |
| Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea Meloxicam, Diclofenac Potassium, Placebo Oral - Dysmenorrhea | Phase 2 / Phase 3 | Completed | Laboratorios Andromaco S.A. | 68 | 2014-06-27 | 2019-05-03 |
| Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF) Elagolix placebo, Elagolix, 0.5 mg estradiol / 0.1 mg norethindrone acetate - Heavy Uterine Bleeding, Uterine Fibroids | Phase 2 | Completed | AbbVie | 571 | 2013-04-08 | 2020-07-21 |
| Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women Flutamide, Placebo - Polycystic Ovary Syndrome (PCOS) | Phase 2 | Completed | University of California, Los Angeles | 23 | 2013-04-01 | 2025-01-10 |
| A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057) Nomegestrol acetate contraceptive vaginal ring (NOMAC-CVR), Etonogestrel containing contraceptive vaginal ring (ENG-CVR), Placebo - Dysmenorrhea | Phase 2 | Completed | Organon and Co | 439 | 2013-01-21 | 2024-05-28 |
| A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD) UC1010, Placebo - Premenstrual Dysphoric Disorder | Phase 1 / Phase 2 | Completed | Umecrine Mood AB | 146 | 2013-01-01 | 2015-01-21 |
| Dexamethasone for Excessive Menstruation Dexamethasone, placebo - Heavy Menstrual Bleeding | Phase 2 | Completed | University of Edinburgh | 123 | 2013-01-01 | 2018-10-25 |
Showing 20 of 49. Sign in to see all of them.
Dysmenorrhea (23) · Amenorrhea (9) · Endometriosis (8) · Pelvic Pain (7) · Premenstrual Syndrome (7) · Dyspareunia (6) · Menorrhagia (6) · Premenstrual Dysphoric Disorder (5) · Infertility (3) · Leiomyoma (3) · Pain (2) · Polycystic Ovary Syndrome (2) · Adenomyosis (1) · Anorexia Nervosa (1)
Pathologic Processes (49) · Pathological Conditions, Signs and Symptoms (49) · Signs and Symptoms (24) · Neurologic Manifestations (23) · Pain (21) · Female Urogenital Diseases (18) · Female Urogenital Diseases and Pregnancy Complications (18) · Genital Diseases (18) · Genital Diseases, Female (18) · Urogenital Diseases (18) · Pelvic Pain (16) · Mental Disorders (12) · Male Urogenital Diseases (7) · Uterine Diseases (7)
asoprisnil (6) · Progesterone (4) · Estradiol (3) · Estrogens, Conjugated (USP) (2) · Ibuprofen (2) · Lidocaine (2) · Meloxicam (2) · Norethindrone Acetate (2) · Sugars (2) · drospirenone (2) · elagolix (2) · estradiol, norethindrone drug combination (2) · Acupuncture Therapy (1) · Acupuncture, Ear (1) · Anastrozole (1)
Abbott (6) · Bayer (4) · University of Johannesburg (3) · Duramed Research (2) · Milton S. Hershey Medical Center (2) · AbbVie (1) · AbbVie (prior sponsor, Abbott) (1) · Asarina Pharma (1) · Beth Israel Deaconess Medical Center (1) · Boehringer Ingelheim (1) · Cairo University (1) · Cedars-Sinai Medical Center (1) · Cornell University (1) · Isifer AB (1) · Juniper Pharmaceuticals, Inc. (1)
United States (18) · Sweden (5) · United Kingdom (5) · South Africa (4) · Poland (3) · Belgium (2) · Canada (2) · Croatia (2) · Germany (2) · Japan (2) · Australia (1) · Austria (1) · Brazil (1) · Bulgaria (1) · Chile (1)
Ana LL Giaponesi (1) · Benicio N Frey, MD, MSc,PhD (1) · Charlotte Owens, MD (1) · Chrisandra Shufelt, MD (1) · Christos S Mantzoros, MD, ScD (1) · Daniel Dumesic, MD (1) · David Bell (1) · Elizabeth Solomon, D.TechHom (1) · George W Creasy, MD (1) · Greta Edelstam, MD (1)
PMID 37523477, PMID 21464293, PMID 21593494, PMID 21660636, PMID 21698665, PMID 21741057, PMID 21833452, PMID 22232129, PMID 22282904, PMID 22617578, PMID 22728230, PMID 23382191, PMID 23921822, PMID 23925396, PMID 24021517, PMID 24703486, PMID 25148234, PMID 25588784, PMID 27733082, PMID 28844356, PMID 30303923, PMID 30439359, PMID 32505383, PMID 32559602, PMID 33045195, PMID 33051459, PMID 34218053, PMID 34668986, PMID 36400597, PMID 37267394, PMID 37365881, PMID 37610989, PMID 37623203, PMID 39097160
2014 (1), M01RR001032 (1), R01DK062249 (1), R21MH062379 (1), R34HD048526 (1)